Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Because GLP-1s impact the parts of the brain involved with reward, researchers began to wonder if they could reduce addictive behaviors
Currently a research peptide, it is hoped in the future it could offer a therapeutic treatment for the following: Hypoactive Sexual Desire Disorder PT-141 peptide stimulates sexual desire and arousal in individuals with hypoactive sexual desire disorder (HSDD) through its unique mechanism of action
Alternative Names: Tesamorelin (GHRH Analog), CJC-1295 (Modified GRF 1-29), Ipamorelin (Synthetic Pentapeptide) Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Studies and Research Data Potential Pituitary Signaling Pathways Research on Tesamorelin and CJC-1295 suggests that they may bind to GHRH receptors, potentially initiating intracellular signaling cascades involving cyclic adenosine monophosphate (cAMP) and protein kinase pathways
References: Andersen, N
Not even a question
